Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
J&J collaborates on consumer health device accelerator
Partners with Shenzhen-based investor firm HAX
Johnson & Johnson is working with Shenzhen-based investor firm HAX on an accelerator programme for novel consumer health devices.
The firm's Johnson & Johnson Innovation arm will work with HAX on supporting start-ups that are developing technologies in areas such as skin care, baby care and wound care.
The world's largest hardware accelerator with bases in Silicon Valley and south east China, HAX has a specific health track within its Shenzhen hardware accelerator.
Companies that have successfully applied to its spring 2017 call for entries and are then co-selected by HAX and J&J will receive mentorship in business development and commercialization from Johnson & Johnson Innovation executives.
They will also, HAX said, learn how to align their products with Johnson & Johnson's consumer health care portfolio.
Featured jobs
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
-
Business Director
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
Subscribe to our email news alerts
- Immunomedics craters after FDA rejects breast cancer ADC
- UK businesses leaning towards second Brexit vote
- NHS England sees off AbbVie's Hep C legal challenge
- China’s clinical trial shake-up
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
PMHub
Complete HealthVizion
Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...
Latest intelligence
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
Quick links
Infographics
